<html style="color:#333;background-color:#eee;font-family:'Calibri';font-size:20">
<head>
<title>Level-2 Topics </title>
<style>
p{ line-height:10px;} 
.div{ margin:0 auto; width:1200px;} 
</style>
</head>
<body>
<div class="div">
<h1 style ="text-align:center"><a style="font-size:20"; href="TopicsTable-Level-3.html">Next Level Up</a>       Level-2 Topics      <a style= "font-size:20" href="TopicsTable-Level-1.html">Next Level Down</a> </h1>
<b style="font-size: 25;">framework issues researchers person perspective existing challenges </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.296 framework researchers person perspective existing describe capture </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.240 issues challenges challenge progress </p>

<b style="font-size: 25;">theory empirical theoretical taking create direction choice </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.304 theory empirical theoretical taking direction choice place </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.439 create created code codes define threshold hearing </p>

<b style="font-size: 25;">cognitive cognition learning tasks task memory attention </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.206 cognitive cognition learning tasks task attention verbal </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.138 memory deficits neuropsychological executive </p>

<b style="font-size: 25;">visual stimuli perception stimulus perceptual object representations </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.118 visual object representations objects vision representation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.099 stimuli perception stimulus perceptual responding respond </p>

<b style="font-size: 25;">abuse substance alcohol drinking marijuana lifetime binge </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.144 abuse substance lifetime suicide </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.112 alcohol drinking marijuana binge heavy </p>

<b style="font-size: 25;">engineering mater eng nanoparticles polymer nanoparticle biomedical </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.093 engineering mater eng polymer biomedical </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.039 nanoparticles nanoparticle carriers aggregation gold nps dox </p>

<b style="font-size: 25;">diet dietary nutrition nutr fat fed feeding </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.114 diet dietary nutrition nutr </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.109 fat fed feeding adipose </p>

<b style="font-size: 25;">users angeles los user cannabis occupational online </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.198 users user cannabis online article </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.127 occupational workers environ environmental </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.142 random estimation weighted randomly bayesian weights assigned </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.111 angeles los california san </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.125 surgery surgical postoperative surg preoperative surgeons underwent </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.069 admission discharge hospitalization intensive icu </p>

<b style="font-size: 25;">addiction cocaine nicotine abstinence smoking dependence cigarette </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.080 addiction cocaine nicotine dependence opioid opioids </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.066 abstinence selfadministration withdrawal relapse nac preference </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.085 smoking cigarette tobacco smokers cigarettes smoke cessation </p>

<b style="font-size: 25;">ieee motion angle applications technique reconstruction speed </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.147 ieee applications technique reconstruction trans phantom </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.154 motion angle speed velocity </p>

<b style="font-size: 25;">algorithm algorithms accuracy accurate validation tool dataset </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.235 algorithm algorithms accuracy accurate </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.258 matching pairs pair matched </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.183 validation tool tools validated utility </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.367 dataset database datasets list </p>

<b style="font-size: 25;">electrical computer electrodes electrode amplitude device recording </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.141 electrical computer device devices </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.084 amplitude electrodes electrode recording </p>

<b style="font-size: 25;">simulation computational simulations modeling constant simulated sets </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.217 sets distributions minimum calculations represented sampling </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.231 phys optimization optimal achieve irradiation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.195 simulation simulations constant simulated shape varying respect </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.259 computational modeling predictions prediction </p>

<b style="font-size: 25;">parameter equation fit coefficient coefficients obtain slope </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.272 coefficient coefficients absolute lowest </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.249 parameter equation fit obtain slope steps </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.371 curve plot plots curves auc </p>

<b style="font-size: 25;">providers provider physician physicians healthcare counseling outpatient </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.213 providers provider counseling adherence </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.207 physician physicians receive barriers decision receiving decisions </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.188 healthcare outpatient emergency hospitals utilization veterans </p>

<b style="font-size: 25;">recommendations insurance medicaid medicare recommended consensus reviewed </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.235 recommendations recommended consensus reviewed </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.098 insurance medicaid medicare coverage </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.087 pubmed investigators epub pmid search doi </p>

<b style="font-size: 25;">bind binds complexes affinity bound assembly motif </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.279 complexes affinity bound assembly formed </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.230 bind binds motif interact </p>

<b style="font-size: 25;">molecules molecule scaffold engineered terminal rapidly docking </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.313 terminal rapidly docking intermediate attachment interference raman </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.305 molecules molecule scaffold scaffolds </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.241 engineered fraction donor clone class fractions clones </p>

<b style="font-size: 25;">residues amino residue cterminal biochemistry conformational nterminal </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.170 residues amino residue biochemistry </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.153 conformational conformation close contact </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.138 cterminal nterminal domain domains </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.107 crystal pdb positions orientation </p>

<b style="font-size: 25;">benefits effectiveness improving costs improvements cost improvement </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.275 benefits effectiveness improving costs cost </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.295 improvements improvement success successful </p>

<b style="font-size: 25;">children child childhood childrens pediatrics pediatric pediatr </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.197 children child childhood childrens childs preschool </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.162 pediatrics pediatric pediatr congenital </p>

<b style="font-size: 25;">disability rehabilitation walking exercise knee gait hip </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.136 disability rehabilitation knee hip joint </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.067 walking exercise gait mobility fracture frailty spine </p>

<b style="font-size: 25;">community people persons staff resources likelihood communities </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.356 resources likelihood caregivers caregiver resource probability </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.292 community people persons communities </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.252 staff team settings implementation planning </p>

<b style="font-size: 25;">services policy practices centers programs awareness accessed </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.274 practices programs awareness seeking efforts </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.277 services policy centers accessed surveillance deaths </p>

<b style="font-size: 25;">fibroblasts remodeling zhou zhao sun zhu regeneration </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.288 fibroblasts remodeling regeneration beta alpha cartilage </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.266 zhou zhao sun zhu lin song chang </p>

<b style="font-size: 25;">regulates induces regulated regulate induction activated receptors </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.317 mediate implicated mediators gamma sensing enhancement inflammasome </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.324 dev disruption alterations developmental </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.312 nuclear nucleus differentially profiles </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.308 upregulation upregulated plays signals contributes </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.328 profiling microarray parallel axis array candidate overlap </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.310 activated activate homeostasis accumulation secretion maintenance alter </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.309 induces induction depletion suppression deficiency nfb autophagy </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.291 regulates regulate promotes regulating downstream activates regulatory </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.290 mature defects maturation defect </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.261 regulated regulator overexpression knockdown </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.309 receptors murine stimulation stimulated </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.250 knockout localization deletion transgenic localized conditional null </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.327 exhibit blocks loop block display exhibited displayed </p>

<b style="font-size: 25;">kinase phosphorylation kinases endogenous transduction tyrosine phosphorylated </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.253 endogenous transduction tyrosine phosphorylated akt pten </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.218 kinase phosphorylation kinases mtor mtorc1 </p>

<b style="font-size: 25;">elements discussed act facilitate examples thought emerging </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.303 discussed act facilitate examples thought emerging basic </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.429 elements element integration integrated </p>

<b style="font-size: 25;">transcription transcriptional promoter reporter enhancer wnt luciferase </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.245 transcription transcriptional wnt catenin notch </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.237 promoter reporter enhancer luciferase </p>

<b style="font-size: 25;">histone chromatin epigenetic methylation embryos embryo cpg </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.115 histone chromatin epigenetic methylation cpg transformation ezh2 </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.094 embryos embryo germ sperm offspring </p>

<b style="font-size: 25;">genome genomic genomewide chromosome locus loci enriched </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.193 genome genomic reads rnaseq library platform </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.192 enriched enrichment copy somatic base protocols repeat </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.173 genomewide chromosome locus loci recombination strand double </p>

<b style="font-size: 25;">sequencing sequences alignment diversity evolution cluster similarity </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.236 sequencing sequences alignment similarity identity </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.171 diversity evolution cluster clusters clustering </p>

<b style="font-size: 25;">interview interviews recruited categories category recruitment classified </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.281 interview interviews recruited recruitment </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.451 categories category classified classification </p>

<b style="font-size: 25;">selfreported participant questionnaire selfreport participation participate bias </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.303 participation participate bias recall </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.293 selfreported participant questionnaire selfreport </p>

<b style="font-size: 25;">marital home married living cultural wellbeing employment </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.222 home living cultural economic residents annual indicators </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.184 marital married wellbeing employment latino </p>

<b style="font-size: 25;">income socioeconomic household urban poverty rural ses </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.190 urban rural job labor spent environments live </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.188 income household mexican city immigrants </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.136 socioeconomic poverty ses neighborhood housing percent explained </p>

<b style="font-size: 25;">demographic race gender covariates eligible ethnicity african </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.387 gender younger men inclusion aged met </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.360 demographic race covariates eligible ethnicity african missing </p>

<b style="font-size: 25;">enrolled enrollment symptom severity pain randomization fatigue </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.218 enrolled enrollment randomization placebo arm </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.219 symptom severity pain fatigue arch signs presentation </p>

<b style="font-size: 25;">hispanic raceethnicity racial ethnic nonhispanic disparities minority </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.185 hispanic raceethnicity nonhispanic whites </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.170 racial ethnic disparities minority </p>

<b style="font-size: 25;">visit visits medication records medications clinic clinicians </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.287 visit visits records retrospective electronic </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.374 medication medications clinic clinicians clinically pilot </p>

<b style="font-size: 25;">epidemiology jama risks epidemiol observational incidence highrisk </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.355 jama risks observational highrisk prescription cumulative </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.352 epidemiology epidemiol incidence diagnosed lancet </p>

<b style="font-size: 25;">predictors predictor confidence multivariate predicting interval predictive </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.307 predictors predictor multivariate predicting predictive worse criterion </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.227 confidence interval intervals hazard cox </p>

<b style="font-size: 25;">logistic odds multivariable stratified womens iqr pvalue </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.271 multivariable stratified womens iqr pvalue boston </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.231 logistic odds ratios incident referent </p>

<b style="font-size: 25;">pcr primers purified primer polymerase purification reverse </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.214 purified purification extracted extraction template forward pol </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.165 pcr primers primer polymerase reverse amplification </p>

<b style="font-size: 25;">rna mrna transcript rnas transcripts splicing exon </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.198 rna mrna splicing exon </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.146 transcript rnas transcripts translation </p>

<b style="font-size: 25;">birth maternal infant infants gestational prenatal mothers </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.093 birth gestational prenatal preterm born </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.103 maternal infant infants mothers mother </p>

<b style="font-size: 25;">pregnancy neonatal pregnant reproductive postnatal delivery fertility </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.080 pregnancy pregnant reproductive fertility </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.081 neonatal postnatal delivery delivered hydrogel hydrogels </p>

<b style="font-size: 25;">tomography scans scan computed pet regional ultrasound </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.145 scans scan pet regional </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.109 tomography computed ultrasound acoustic </p>

<b style="font-size: 25;">image voxels roi axial acquired slices acquisition </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.087 voxels axial roi slices volumes registration row </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.114 image acquired acquisition segmentation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.103 diffusion fluid permeability csf </p>

<b style="font-size: 25;">mri resonance magnetic neuroimage neuroimaging fmri matter </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.107 resonance magnetic matter subject </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.107 mri neuroimage neuroimaging fmri </p>

<b style="font-size: 25;">reson magn pulse relaxation conventional segment segments </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.082 conventional segment segments residual advantage distal proximal </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.054 reson magn pulse relaxation </p>

<b style="font-size: 25;">kit cultured medium supplemented cdna technologies grown </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.239 kit cdna technologies technology </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.211 cultured medium supplemented media grown cultures </p>

<b style="font-size: 25;">washed pbs maintained fetal ethanol chamber cold </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.249 washed pbs fetal ethanol cold tail </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.309 maintained chamber oil facility post pre minor </p>

<b style="font-size: 25;">incubated buffer overnight incubation temperature sigma prepared </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.287 sigma nacl hour carried immediately band contained </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.277 incubated buffer prepared purchased gel assays lysates </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.264 overnight incubation temperature gml mgml </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.281 transferred experiment normalized subjected fold beads loading </p>

<b style="font-size: 25;">plates plate sodium saline phosphate dmso stored </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.279 saline phosphate stored dry storage </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.256 plates plate sodium dmso vehicle salt figs </p>

<b style="font-size: 25;">extracellular collagen mesenchymal matrix stromal ecm integrin </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.197 mesenchymal stromal integrin tgf deposition fibrosis smooth </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.151 extracellular collagen matrix ecm </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.135 wound healing skin hair cochlear </p>

<b style="font-size: 25;">layer mechanical channels channel layers outer surfaces </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.189 layer layers outer surfaces adjacent shear boundary </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.088 mechanical stiffness force displacement </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.104 channel channels sensor sensors </p>

<b style="font-size: 25;">stem marrow hematopoietic progenitor lineage bone progenitors </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.193 marrow hematopoietic lineage bone expansion </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.147 stem progenitor progenitors embryonic </p>

<b style="font-size: 25;">leukemia myeloid transplantation lymphoma transplant aml recipients </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.108 leukemia myeloid lymphoma aml </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.087 transplantation transplant recipients graft rejection hct tbi </p>

<b style="font-size: 25;">membrane intracellular membranes actin blot cytoplasmic trafficking </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.333 membrane intracellular cytoplasmic trafficking transport translocation intact </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.235 membranes actin blot western </p>

<b style="font-size: 25;">proliferation apoptosis differentiation adhesion migration apoptotic arrest </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.265 proliferation differentiation migration adhesion </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.204 apoptosis apoptotic arrest initiation unclear event </p>

<b style="font-size: 25;">inhibits inhibitor inhibit inhibitors inhibited enhances ligand </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.353 ligand resistance ligands resistant </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.317 enhances blocking soluble pharmacological reduces enhance released </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.322 inhibits inhibit inhibited inhibitory modulation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.309 inhibitor inhibitors protease degradation cleavage </p>

<b style="font-size: 25;">potent agents therapeutics antagonist blockade preclinical agonist </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.261 potent agents therapeutics preclinical agent </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.193 antagonist blockade agonist agonists </p>

<b style="font-size: 25;">animals injection injected mgkg exposed injections heat </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.436 exposed heat shock exposures </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.252 animals injection injected mgkg injections </p>

<b style="font-size: 25;">rat rats physiol physiology physiological calcium prolonged </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.275 prolonged transient attenuated sustained recovery implantation sham </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.260 rat rats perfusion anesthesia </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.293 physiol physiology physiological calcium </p>

<b style="font-size: 25;">damage mitochondrial mitochondria injury repair atp cytochrome </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.271 damage injury repair injuries </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.108 mitochondrial mitochondria atp cytochrome bcl2 cysteine mtdna </p>

<b style="font-size: 25;">oxygen pharmacol reactive oxide nitric protective ther </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.202 pharmacol oxide nitric protective ther protection </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.130 oxygen reactive radical psa </p>

<b style="font-size: 25;">dose doses toxicity dosing administered infusion safety </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.213 toxicity safety adverse toxic </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.212 dose doses dosing administered infusion regimen </p>

<b style="font-size: 25;">pulmonary lung respiratory lungs airway alveolar morbidity </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.151 respiratory airway morbidity sepsis pneumonia </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.131 pulmonary lung lungs alveolar </p>

<b style="font-size: 25;">cortex cortical hippocampus prefrontal hippocampal frontal dorsal </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.141 cortex cortical hippocampus hippocampal connectivity networks </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.133 prefrontal frontal dorsal ventral medial gyrus </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.201 onset movement movements delayed delay familial </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.093 lobe parietal correct correction false true </p>

<b style="font-size: 25;">striatum dopamine glial dopaminergic striatal astrocytes cerebellar </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.119 striatum striatal cerebellar projections pfc myelin </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.069 dopamine dopaminergic transporter serotonin </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.060 glial astrocytes microglia barrier bbb </p>

<b style="font-size: 25;">neuroscience neural amygdala reward cues eeg latency </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.172 neuroscience neural cues eeg latency video </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.171 amygdala reward timing motivation window periods tracking </p>

<b style="font-size: 25;">anterior lateral posterior bilateral head inferior superior </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.159 head inferior superior neck </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.153 anterior lateral posterior bilateral </p>

<b style="font-size: 25;">spatial space resolution temporal distance mapping noise </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.269 spatial space temporal distance locations located </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.231 resolution mapping noise maps map depth deep </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.315 dynamic dynamics transition transitions </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.247 input output start starting back </p>

<b style="font-size: 25;">synaptic synapses plasticity glutamate nmda gaba interneurons </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.108 interneurons olfactory currents conditioning resting subtypes extinction </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.102 synaptic synapses plasticity glutamate nmda gaba transmission </p>

<b style="font-size: 25;">alzheimers dementia parkinsons aging elderly decline synuclein </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.093 alzheimers dementia parkinsons synuclein </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.140 aging elderly decline supplementation vitamin </p>

<b style="font-size: 25;">neurosci neuron neurol cerebral nervous cns degeneration </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.196 neurosci neuron neurol cerebral </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.203 nervous cns degeneration atrophy sclerosis progressive </p>

<b style="font-size: 25;">neurological neurology dysfunction impaired impairment epilepsy abnormalities </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.158 neurological neurology epilepsy seizures seizure </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.251 dysfunction impaired impairment abnormalities syndrome abnormal </p>

<b style="font-size: 25;">neurons neuronal motor brains sensory neurogenesis circuit </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.169 motor sensory spontaneous intrinsic ablation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.154 neurons neuronal brains circuit neurogenesis firing bdnf </p>

<b style="font-size: 25;">axonal nerve axons spinal axon cord fibers </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.103 nerve spinal cord fibers optic fiber sympathetic </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.072 axonal axons axon root drg comparative </p>

<b style="font-size: 25;">kidney muscle renal hormone oral skeletal endocrine </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.142 kidney renal dialysis ckd </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.176 oral urinary urine dental </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.202 muscle skeletal muscles limb </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.090 hormone endocrine testosterone androgen </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.034 amyloid apoe tau plaque </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.136 plt005 plt001 plt0001 plt00001 </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.034 eye ocular ophthalmol retinal retina eyes </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.154 academy proceedings america european official </p>

<b style="font-size: 25;">liver hepatic organs organ hepatocytes bile lymph </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.215 organs organ lymph nodes node </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.187 liver hepatic hepatocytes bile </p>

<b style="font-size: 25;">metabolism metabolic lipid metabolites lipids cholesterol metabolite </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.223 metabolism metabolic metabolites metabolite </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.149 lipid lipids cholesterol hdl </p>

<b style="font-size: 25;">metab glucose insulin endocrinol diabetic hba1c metformin </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.183 metab endocrinol diabetic metformin neuropathy </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.139 glucose insulin hba1c hemoglobin </p>

<b style="font-size: 25;">diabetes hypertension intake complications consumption comorbidities food </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.227 diabetes hypertension complications comorbidities burden </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.156 intake consumption food daily week </p>

<b style="font-size: 25;">obesity obese bmi overweight height eating leptin </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.138 bmi overweight height eating foods </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.123 obesity obese leptin gain hfd </p>

<b style="font-size: 25;">cardiovascular artery circulation coronary systolic pressure mgdl </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.176 cardiovascular artery circulation coronary </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.148 systolic pressure mgdl cvd </p>

<b style="font-size: 25;">vascular atherosclerosis arterial endothelial stroke carotid vessels </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.142 atherosclerosis arterial stroke carotid hypoxia hif1 </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.152 vascular endothelial vessels vessel </p>

<b style="font-size: 25;">myocardial infarction cardiac ischemic ventricular aortic ischemia </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.122 myocardial infarction ischemic ischemia </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.109 cardiac ventricular aortic atrial hearts valve wall </p>

<b style="font-size: 25;">cytokines cytokine proinflammatory tnf necrosis systemic antiinflammatory </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.203 cytokines cytokine systemic circulating autoimmune peripheral invest </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.147 proinflammatory tnf necrosis antiinflammatory </p>

<b style="font-size: 25;">immune immunol immunity innate immunology ifn lymphocytes </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.158 immune immunol lymphocytes tcell antigen antigens </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.140 immunity innate ifn adaptive clearance spleen adaptation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.135 immunology effector allergy allergic asthma ige </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.096 dendritic subsets mhc immunotherapy tcr dcs subset </p>

<b style="font-size: 25;">macrophages macrophage monocytes lps platelet platelets transfusion </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.140 macrophages macrophage monocytes lps </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.055 platelet platelets transfusion sickle hscs scd </p>

<b style="font-size: 25;">inflammatory inflammation pathogenesis neutrophils pathology neutrophil pathological </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.197 inflammatory inflammation mast eosinophils </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.308 pathogenesis pathology pathological pathogenic </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.082 neutrophils neutrophil complement hcc ecs hsp90 postpartum </p>

<b style="font-size: 25;">microbiol strains coli strain vaccine vaccination vaccines </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.117 microbiol strains coli strain </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.062 vaccine vaccination vaccines immunization influenza </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.102 gut intestinal gastrointestinal gastroenterology intestine bowel colitis </p>

<b style="font-size: 25;">bacterial bacteria host pathogens microbial virulence antibiotic </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.136 microbial mucosal aureus fungal plant </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.131 host pathogens antibiotic antibiotics microbiota microbiome </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.117 bacterial bacteria virulence biofilm </p>

<b style="font-size: 25;">infection infect infections infectious infected dis tuberculosis </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.181 infection infections infectious tuberculosis parasite malaria </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.148 infect infected dis suppl </p>

<b style="font-size: 25;">virus viral hiv viruses virol antiretroviral hivinfected </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.124 virus viral viruses virol replication load rice </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.062 hiv aids antiretroviral hivinfected hiv1 art </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.110 africa countries world south organization west </p>

<b style="font-size: 25;">antibody antibodies expressing monoclonal express cytometry igg </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.288 expressing express cytometry epithelial viability elisa epithelium </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.274 antibody antibodies monoclonal igg recombinant rabbit kda </p>

<b style="font-size: 25;">staining stained sections quantification quantified sem marker </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.243 staining stained quantification quantified marker differentiated </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.236 sections sem fixed anova </p>

<b style="font-size: 25;">fluorescence fluorescent labeled probes particles probe labeling </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.255 fluorescence fluorescent labeled labeling situ fish </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.230 probes probe particles emission particle excitation </p>

<b style="font-size: 25;">plasmid transfected transfection gfp vector vectors sirna </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.164 plasmid gfp constructs construct </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.227 vector vectors efficiency efficient </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.113 transfected transfection sirna untreated </p>

<b style="font-size: 25;">bar bars bottom yellow arrows figures color </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.386 bottom yellow arrows color middle </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.241 bar bars figures supplemental </p>

<b style="font-size: 25;">microscope microscopy confocal nuclei morphology diameter optical </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.247 microscope microscopy confocal nuclei morphology optical laser </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.258 diameter glass filter tube thickness tip solutions </p>

<b style="font-size: 25;">mutant wildtype mutants subunit wild subunits drosophila </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.297 subunit subunits drosophila modifications elegans modification acetylation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.224 mutant wildtype mutants wild </p>

<b style="font-size: 25;">polymorphisms nucleotide snps snp genotype genotypes susceptibility </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.098 polymorphisms nucleotide snps snp susceptibility </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.067 genotype genotypes gwas ancestry traits trait </p>

<b style="font-size: 25;">mutations mutation phenotype phenotypes encoding phenotypic fusion </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.339 phenotype phenotypes encoding phenotypic fusion specificity origin </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.318 mutations mutation novo dominant proteomics exchange </p>

<b style="font-size: 25;">genet reveals variants genetics variant allele discovery </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.316 reveals discovery insights architecture feature </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.230 genet genetics allele alleles hum </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.196 variants variant rare frequent </p>

<b style="font-size: 25;">tumors cancers carcinoma metastatic metastasis malignant melanoma </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.172 tumors cancers carcinoma kras ras </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.169 malignant melanoma glioblastoma glioma gbm </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.167 biopsy specimens cervical hpv </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.161 metastatic metastasis tumour invasion microenvironment </p>

<b style="font-size: 25;">breast prostate colorectal adenocarcinoma antitumor ovarian colon </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.185 antitumor solid cytotoxicity egfr cycles cat </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.172 breast prostate ovarian estrogen endometrial </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.161 colorectal adenocarcinoma colon pancreatic </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.163 mammary gland bladder thyroid </p>

<b style="font-size: 25;">oncol oncology chemotherapy metastases radiation recurrence radiotherapy </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.161 oncol oncology chemotherapy metastases radiation recurrence radiotherapy </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.291 therapies treat treatments engl </p>

<b style="font-size: 25;">prognostic prognosis aggressive biomarkers lesions angiogenesis biomarker </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.191 aggressive biomarkers lesions angiogenesis biomarker lesion vegf </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.157 prognostic prognosis cohorts subgroup heterogeneity </p>

<b style="font-size: 25;">language english sessions session training words trained </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.175 language english words word </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.171 session sessions training trained </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.217 examining correlations variance variability sizes averaged indices </p>

<b style="font-size: 25;">items asked item validity reliability respondents scales </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.234 asked respondents scales dimensions </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.226 items item validity reliability </p>

<b style="font-size: 25;">attitudes beliefs personal violence sexual communication stigma </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.170 attitudes beliefs personal communication </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.105 sexual violence stigma partner partners victimization condom </p>

<b style="font-size: 25;">skills educational goals academic achievement literacy comprehension </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.184 skills educational literacy comprehension reading </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.168 goals academic achievement goal </p>

<b style="font-size: 25;">psychological psychology behaviors experiences personality ratings rating </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.259 experienced engagement concerns month selfefficacy </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.259 washington metaanalysis retrieved fewer asian adjustment student </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.264 behaviors experiences fear contextual </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.254 difficulties difficulty face facial faces </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.284 ratings rating assessments standardized manual </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.220 psychological psychology personality anger </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.317 consequences influences correlates colleagues causal link cohen </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.203 relations coded expectations satisfaction relation coding </p>

<b style="font-size: 25;">mental emotional depressive psychosocial problems disorder affective </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.219 psychosocial problems affective functioning psychopathology problem subjective </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.206 mental depressive disorder mood </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.149 emotional coping emotion distress cortisol reactivity </p>

<b style="font-size: 25;">psychiatry psychiatric psychol illness behav schizophrenia comorbid </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.195 schizophrenia psychosis bipolar diagnoses diagnostic </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.196 psychiatry psychiatric comorbid comorbidity impulsivity adhd </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.203 psychol illness behav nursing </p>

<b style="font-size: 25;">depression anxiety posttraumatic suicidal moderate ptsd ideation </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.183 moderate generalized mild episodes term mdd </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.159 depression anxiety suicidal ideation </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.091 posttraumatic ptsd traumatic trauma </p>

<b style="font-size: 25;">parents parental parent families parenting females fathers </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.294 females males students positively negatively ttest chinese </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.099 parents parental parent families parenting fathers </p>

<b style="font-size: 25;">adolescent adolescents adolescence youth longitudinal girls adulthood </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.158 longitudinal girls boys crosssectional </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.142 adolescent adolescents adolescence youth adulthood ages schools </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.083 trajectories externalizing internalizing trajectory late latent stages </p>

<b style="font-size: 25;">biochem biophys peptide chain peptides biochemical fragment </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.359 chain products fragment fragments yeast product chains </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.303 biochem biophys biochemical acta </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.275 peptide peptides stability instability </p>

<b style="font-size: 25;">acids mammalian conserved nucleic fatty amounts energy </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.388 mammalian conserved amounts composition excess </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.302 acids nucleic fatty energy restriction appendix insertion </p>

<b style="font-size: 25;">species oxidative oxidation abundance redox antioxidant ros </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.354 species abundance iron heme </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.160 oxidative oxidation redox ros antioxidant </p>

<b style="font-size: 25;">enzyme enzymes substrate catalytic substrates biosynthesis precursor </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.271 enzyme enzymes biosynthesis precursor </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.241 substrate catalytic substrates reactions conversion </p>

<b style="font-size: 25;">compounds lett synthesized synthetic compound derivatives carbon </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.267 synthesized synthetic coupling coupled </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.274 kinetics kinetic selectivity acc neutral soft </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.265 lett carbon gas appl toxicol </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.190 compounds compound derivatives ring </p>

<b style="font-size: 25;">chemical chemistry solvent electron ion hydrogen ions </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.235 hydrophobic charge metal xray absorption interface thermal </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.225 electron ion ions spectroscopy mode dimer </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.214 chemical chemistry solvent hydrogen aqueous organic bond </p>

<b style="font-size: 25;">chromatography liquid spectrometry peak peaks column fast </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.146 chromatography liquid spectrometry column anal gradient calibration </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.178 peak peaks fast slow </p>

<b style="font-size: 25;">spectra nmr ppm mhz spectrum scheme proton </b>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.108 scheme yield mmol shifts shift </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.106 spectra nmr ppm mhz proton cdcl3 </p>
<p style="text-indent:2em;">&nbsp;&nbsp;&nbsp;&nbsp; 0.267 spectrum spectral autism asd </p>

</div>
</body>
</html>
